6509--Solifenacin Tabletes (VA-25-00037090)
ID: 36E79725R0020Type: Presolicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNAC PHARMACEUTICALS (36E797)HINES, IL, 60141, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS, VETERINARY USE (6509)

Original Source

https://sam.gov/opp/08a523a7a83642d2b07852e160584c72/view
Timeline
    Description

    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Solifenacin Tablets, aimed at ensuring a reliable supply for the VA, Department of Defense (DoD), and other federal health agencies. This unrestricted procurement will award one contract with a term of one year plus four optional renewal periods, requiring offerors to provide specific labeling, packaging details, and compliance with the Drug Supply Chain Security Act. The estimated annual requirements include various packaging sizes and quantities of Solifenacin, reflecting the VA's commitment to maintaining a consistent supply of essential medications for veterans and associated healthcare providers. Interested vendors should monitor SAM.gov for the solicitation release on or around March 14, 2025, with a response deadline of March 28, 2025; inquiries can be directed to Kenneth Lay at Kenneth.Lay@va.gov or by phone at 708-786-4879.

    Point(s) of Contact
    Kenneth LayContract Specialist
    (708) 786-4879
    Kenneth.Lay@va.gov
    Files
    Title
    Posted
    36E79725R0020_1.docx
    The document outlines a solicitation for pharmaceutical products to be supplied to the Department of Veterans Affairs and other authorized entities such as the Department of Defense and Indian Health Service. The primary purpose is to establish a contractual agreement that ensures the availability and pricing of specific drugs, including Tadalafil tablets in various dosages. Offerors are required to submit competitive pricing for the base year and four option years, including a 0.5% Cost Recovery Fee embedded in all prices. The contract mandates compliance with the Drug Supply Chain Security Act and includes stipulations regarding product registration, packaging, and reporting requirements. Additionally, there is a focus on manufacturers maintaining Good Manufacturing Practices (GMP) to ensure quality and safety. The contract will be administered through Prime Vendor Programs, which facilitate pharmaceutical distribution to several government participants. The document emphasizes objectives such as ensuring consistent product availability, compliance with regulations, and establishing business relationships between contractors and prison facilities. It serves as a comprehensive framework for vendors to understand submission expectations, product specifications, and compliance requirements for effective contract execution.
    36E79725R0020.docx
    The Department of Veterans Affairs (VA) is planning to issue Request for Proposal (RFP) 36E79725R0020 for the procurement of Solifenacin Tablets, aiming to secure a reliable supply for the VA, Department of Defense (DoD), and other federal health agencies. This unrestricted procurement will award one contract, with a term of one year plus four optional renewal periods. Offerors must provide specific labeling and packaging details, including unique NDC numbers and safety-cap requirements for the bottles. The RFP will be made available electronically on or around March 14, 2025, with a response deadline of March 28, 2025. Each interested vendor is encouraged to monitor SAM.gov for updates and potential amendments. Estimated annual requirements include various packaging sizes and quantities of Solifenacin, demonstrating the VA's commitment to streamlined procurement of essential medications for veterans and associated healthcare providers.
    36E79725R0020 0001 amendment.docx
    The document outlines a solicitation for the Department of Veterans Affairs (VA) to procure certain pharmaceutical products through its VA Pharmaceutical Prime Vendor (PPV) Program. The main objective is to establish competitive national contract prices for specified drugs, including Solifenacin Succinate tablets, ensuring consistent availability across various VA and Department of Defense healthcare facilities. The solicitation requires bidders to submit prices for both the base year and four option years, adhering to stringent requirements regarding drug sourcing, packaging, and compliance with the Drug Supply Chain Security Act (DSCSA). Participants must provide unique National Drug Code (NDC) numbers for each product, maintain Good Manufacturing Practices (cGMP) as certified by the FDA, and report sales quarterly, including a Cost Recovery Fee of 0.5%. Amendments are included to correct the solicitation, but the offer due date remains the same. The winning contractor will receive orders through the PPV, emphasizing the importance of robust vendor agreements and inventory management. This initiative reflects the government's commitment to ensuring effective procurement processes and healthcare delivery while adhering to federal regulations.
    Lifecycle
    Title
    Type
    6509--Solifenacin Tabletes (VA-25-00037090)
    Currently viewing
    Presolicitation
    Similar Opportunities
    6505--Ustekinumab Pens/Syringes or Biosimilar
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Ustekinumab Pens/Syringes or Biosimilars, aimed at supplying various federal health entities including the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The contract will be awarded for an initial period of one year, with the possibility of four additional one-year option periods, ensuring a consistent supply of these critical pharmaceutical products through the VA and DoD Pharmaceutical Prime Vendor Programs. Offerors must provide drugs with unique National Drug Code (NDC) numbers and ensure that any biosimilar products meet FDA licensing requirements, as outlined in the FDA Purple Book. The solicitation is expected to be released around January 12, 2026, with a tentative closing date of January 27, 2026; interested parties should direct inquiries to Chris Carthron at Christopher.Carthron@va.gov or (708) 786-4980.
    Pharmaceutical Repackaging Services for National CMOP (770)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for pharmaceutical repackaging services for the National Consolidated Mail Outpatient Pharmacy (CMOP) program. The contract, identified as 36C77026R0004, is a firm-fixed-price, indefinite-delivery agreement intended to support the repackaging of government-purchased oral solid pharmaceuticals into various bottle sizes for distribution to over 7 million veterans. The contract spans a five-year ordering period from February 1, 2026, to January 31, 2031, with a potential six-month extension, and has a minimum value of $20 million and a maximum value of $125 million. Interested contractors should contact Renee Kreutzer at renee.kreutzer@va.gov for further details and must submit their proposals by the specified deadlines, ensuring compliance with all relevant regulations and standards.
    6505--Nicotine Lozenges MINI (VA-26-00020754)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Nicotine Mini Lozenges, specifically under solicitation number 36E79726R0007. This contract aims to ensure an uninterrupted supply of nicotine lozenges for the VA, Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS), with a contract duration of one year and four optional one-year extensions. The estimated annual requirements include 166,791 bottles of 2mg lozenges and 138,276 bottles of 4mg lozenges, which will be distributed through the VA and DOD Pharmaceutical Prime Vendor Programs. Interested offerors should note that the solicitation will be electronically issued around December 18, 2025, with a tentative closing date of January 1, 2026, and can direct inquiries to Billy Fong at billy.fong@va.gov or by phone at 708-786-4992.
    6505--LEVOFLOXICIN 750MG / DEXTROSE 5% 150ML, IVPB (VA-26-00008212)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking small business vendors to supply LEVOFLOXICIN 750MG / DEXTROSE 5% 150ML, IVPB, as part of solicitation number 36C77026Q0005. This procurement involves delivering a total of 1,460 boxes of the pharmaceutical product to the VA CMOP facility in Hines, Illinois, with a base period and four option years, each requiring delivery by January 5th of the respective year. The goods are critical for patient care within the VA healthcare system, emphasizing the importance of timely and compliant delivery. Interested vendors must submit their proposals, including a signed SF 1449, pricing schedule, and other required documentation, by December 16, 2025, at 3 PM Central Time, and can direct inquiries to Contract Specialist Jennifer Coleman at Jennifer.Coleman4@va.gov.
    Dimethyl Fumarate DR Presolicitation
    Dept Of Defense
    The Defense Logistics Agency (DLA) is planning to issue a solicitation for a national requirements contract for Dimethyl Fumarate DR capsules, specifically 120MG capsules in 14 count bottles and 240MG capsules in 60 count bottles. This procurement aims to establish a reliable national supply source for these pharmaceutical products, which are essential for Department of Defense (DoD) customers through the DLA prime vendor program. The contract will be a firm-fixed price, requirements type contract with a one-year base period and four one-year options, emphasizing compliance with federal regulations and efficient distribution of pharmaceuticals for military healthcare. Interested parties should contact Kevin Rafferty at kevin.rafferty@dla.mil or 215-737-0907 for further inquiries, and the projected solicitation date is February 2021, with an amendment extending the offer submission deadline to October 14, 2021, at 3:00 PM EST.
    Ondansetron Orally Disintegrating Tablets
    Dept Of Defense
    The Defense Logistics Agency (DLA) is planning to issue a solicitation for a national requirements contract for Ondansetron Orally Disintegrating Tablets (ODT), specifically 4 MG and 8 MG tablets in various count bottles. This procurement aims to establish a national supply source for these pharmaceutical products, which are critical for treating nausea and vomiting in patients, and will be available for purchase by the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options, and is expected to be solicited in September 2025, although the DLA reserves the right to issue it earlier or later. Interested parties should direct inquiries to Nancy Fernandez at nancy.fernandez@dla.mil or call 445-737-0713, and are encouraged to set up automated notifications for any changes to the solicitation through the DLA Bid Board System and Sam.Gov.
    NATIONAL OPERATIONAL/MAILING SUPPLIES
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for operational and mailing supplies through solicitation number 36C77025R0004, aimed at supporting its seven Consolidated Mail Outpatient Pharmacy (CMOP) locations. This procurement involves establishing multiple National Single Award Indefinite Delivery/Indefinite Quantity (IDIQ) contracts for essential items such as corrugated boxes, bubble mailers, sealing tape, and child-resistant medical pouches, ensuring compliance with stringent specifications for patient safety and product integrity. The awarded contracts will facilitate timely deliveries of these supplies, which are critical for the efficient processing and shipment of prescriptions to veterans. Interested vendors must submit their proposals, including product samples and pricing schedules in Excel format, by the extended deadline of January 15, 2026, at 5:00 PM CDT. For further inquiries, contact Kelly L Mann at kelly.mann@va.gov or Kelley Cunningham at kelley.cunningham@va.gov.
    Metaxalone Tablets
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is soliciting proposals for the supply of Metaxalone 800 MG tablets, available in 100-count and 500-count bottles. This procurement aims to establish a requirements contract with estimated annual quantities for a base year and four option years, emphasizing the need for compliance with various federal acquisition regulations and ethical standards. Metaxalone is a critical medication used for muscle relaxation, making this contract vital for supporting military health services. Interested vendors must submit their proposals electronically via the Defense Logistics Agency Internet Bid Board System (DIBBS) between November 7 and December 7, 2025, by 3:00 PM EST. For further inquiries, contact Jeremy Brown at jeremy.brown@dla.mil or Jason Wray at Jason.wray@dla.mil.
    6505--Zonisamide Capsules
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified suppliers for a Firm Fixed Price, Indefinite-Delivery Requirements contract for Zonisamide Capsules in 25mg, 50mg, and 100mg dosages. Offerors are required to provide pricing for a base year and four option years, submit a 0.5% Cost Recovery Fee, and comply with stringent packaging and barcoding standards, including adherence to the Drug Supply Chain Security Act (DSCSA) and National Drug Code (NDC) requirements. These pharmaceutical products are crucial for the healthcare services provided to veterans and military personnel through the VA and DoD Pharmaceutical Prime Vendor Programs. Interested parties should contact Contract Specialist Christopher Carthron at Christopher.Carthron@va.gov for further details, and ensure they meet all compliance and registration requirements, including current SAM registration.
    760-25-1-050-0154 -Leavenworth CMOP THYROID TABLETS -(VA-25-00022614)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Armour Thyroid tablets for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0079. This Request for Quotation (RFQ) emphasizes the need for specific brand-name pharmaceuticals, with a focus on compliance with federal regulations, including the Drug Supply Chain Security Act and the Buy American Act. The procurement process aims to ensure a reliable supply of essential medications for veterans, with a firm-fixed-price contract expected to be awarded based on fair market evaluations. Interested vendors must submit their quotes by December 27, 2024, at 4:00 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.